Build resilient systems at scale
28–30 October 2015 • Amsterdam, The Netherlands

A day in the life - An immersive data experience

David Boloker (IBM Corporation)
9:55–10:05 Friday, 30/10/2015
Location: Auditorium
Average rating: ***..
(3.76, 66 ratings)

A day in the life today is awash with multi-modal inputs from all disparate parts of one’s life from work to social to family. We’ll explore how we can gain cognitive insights and efficiencies using new and evolving interaction patterns.

The focus will be on application experiences becoming contextual across a variety of device endpoints, enabling data to come to us in context when needed all using the virtues of Cloud Computing and Micro-Services.

This keynote is sponsored by IBM

Photo of David Boloker

David Boloker

IBM Corporation

David Boloker is CTO of IBM’s Emerging Internet Technology group and also holds the title of distinguished engineer. David is also responsible for forming IBM’s technical strategy around the emerging areas of mobile identity and gaining insights from big data. In this role, he leads an globally distributed IBM team researching new areas in software design and development. Previously, he was responsible for the commercialization of the Watson machine. David and his team took the system that played Jeopardy and created a multipurpose machine that can analyze information and provide solutions across the industry from healthcare to finance to retail.

Throughout David’s extensive career at IBM, he has held the role of CTO for Java technology, and he’s worked at IBM’s esteemed Thomas J. Watson Research Center as well as the Cambridge Scientific Center doing research in the area of remote distribution and control of hardware and software systems and secure Internet gateways. David has also developed an Internet-based data exploration tool to support development and testing of hypotheses regarding complex genetic and environmental relationships in the development of chronic obstructive lung disease (COPD) in collaboration with COPDGene investigators in the Brigham and Women’s Hospital Center for Advanced Medical Imaging and COPDGene.